Recent Advances in Analytical Methods for Antibody-Drug Conjugates (ADCs): From In Vitro to In Vivo (Part 2)
Good article to read: Abstract: In the past decade, antibody-drug conjugates (ADCs) have sparked a new wave of development in the biopharmaceutical market due to their high efficacy in cancer treatment. As of now, the U.S. Food and Drug Administration (FDA) has approved 13 types of ADCs for clinical treatment. The development of ADCs relies … Read more